BX004
FailedCystic Fibrosis, P. aeruginosa lung infections
DiscontinuedStock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| BX004 | Cystic Fibrosis, P. aeruginosa lung infections | Failed | TBA | — |
Upcoming milestones
Cystic Fibrosis, P. aeruginosa lung infections
DiscontinuedCompany profile
BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies. The company's portfolio targets various niches, such as counter-drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting. It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers. The company was founded in 2015 and is based in Dover, Delaware.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.